A selenomethionine-containing composition and its preparation method and application

Through the combination of L-selenomethionine, L-selenium-methylselenium cysteine, L-theanine, cod liver peptide and enzymatic lysate, the problems of poor efficacy of liver fibrosis treatment and improper selenium dosage in the prior art were solved, and efficient and safe treatment effects of liver fibrosis were achieved.

CN118845984BActive Publication Date: 2025-03-25ANKANG CENT HOSPITAL
2 Cites 0 Cited by

Patent Information

Application Number
CN202410827131.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-06-25
Publication Date
2025-03-25
Estimated Expiration
2044-06-25

AI Technical Summary

Technical Problem

The prior art has poor efficacy in treating liver fibrosis, and the improper dosage of selenium in drugs containing selenium can easily cause cytotoxicity, and the effect of simple low-level selenium content to improve liver fibrosis is not good.

Method used

The combination of L-selenomethionine, L-selenium-methylselenium cysteine, L-theanine, cod liver peptide and terrestris terrestris enzymatic solution is used to improve the absorption rate of selenium and liver enrichment through specific ratios and preparation methods, and enhance immune ability and antiviral properties.

Benefits of technology

It achieved very excellent liver fibrosis treatment effect under low dose treatment, significantly reduced the levels of relevant liver enzymes and inflammatory factors, increased the Se4+ content in the serum and liver, ensured safety, and avoid selenium poisoning.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention relates to a selenomethionine-containing composition and a preparation method and application thereof, belonging to the field of biomedical technology. The composition is compounded with L-selenomethionine, L-selenomethylselenocysteine, L-theanine, monkfish liver peptide and Tribulus terrestris enzymolyte, and each component has a good synergistic effect, and can achieve a very excellent liver fibrosis treatment effect. Among them, the combination of L-selenomethionine and L-selenomethylselenocysteine ​​can promote the absorption rate of selenium, can control and appropriately increase the liver enrichment of selenium, achieve a higher immune ability, improve the liver's antiviral property, is safe and reliable, and will not cause selenium poisoning. L-theanine can promote the effective absorption of L-selenomethionine and L-selenomethylselenocysteine. Monkfish liver peptide and Tribulus terrestris enzymolyte are prepared by a special process, both have a good liver fibrosis treatment effect, and effectively alleviate the development process of liver fibrosis.
Need to check novelty before this filing date? Find Prior Art